28468761|t|CD177 (+) neutrophils as functionally activated neutrophils negatively regulate IBD
28468761|a|Neutrophils are accumulated in inflamed mucosa of IBD and play an important role in the pathogenesis. CD177 is expressed in neutrophils specifically and upregulated during inflammation. However, the role of CD177(+) neutrophils in pathogenesis of IBD remains elusive. Expression of CD177 was analysed in peripheral blood and intestinal mucosa from patients with IBD using quantitative RT-PCR, flow cytometry and immunohistochemistry. CD177(+) and CD177(-) neutrophils were isolated to determine gene differences by RNA sequencing. Colitis was established in CD177(-/-) and wild-type mice in response to dextran sulfate sodium (DSS) insults to determine the role of CD177(+) neutrophils in IBD. CD177(+) neutrophils were markedly increased in peripheral blood and inflamed mucosa from patients with active IBD compared with healthy controls. RNA sequencing revealed that differential gene expression between CD177(+) and CD177(-) neutrophils from patients with IBD was associated with response to bacterial defence, hydrogen peroxide and reactive oxygen species (ROS). CD177(+) neutrophils produced lower levels of proinflammatory cytokines (ie, interferon-γ, interleukin (IL)-6, IL-17A), but higher levels of IL-22 and transforming growth factor-β, and exhibited increased bactericidal activities (ie, ROS, antimicrobial peptides, neutrophil extracellular trap) compared with CD177(-) subset. CD177(-/-) mice developed more severe colitis on DSS insults compared with wild-type mice. Moreover, CD177 deficiency led to compromised intestinal barrier and impaired antibacterial immunity through decreased production of IL-22 by CD177(-) neutrophils. CD177(+) neutrophils represent functionally activated population and play a protective role in IBD through increased bactericidal activity and IL-22 production. Targeting CD177 (+) neutrophils may be beneficial for treatment of IBD.
28468761	0	5	CD177	T028	C1824675
28468761	10	21	neutrophils	T025	C0027950
28468761	48	59	neutrophils	T025	C0027950
28468761	80	83	IBD	T047	C0021390
28468761	84	95	Neutrophils	T025	C0027950
28468761	115	130	inflamed mucosa	T033	C3671082
28468761	134	137	IBD	T047	C0021390
28468761	172	184	pathogenesis	T046	C0699748
28468761	186	191	CD177	T028	C1824675
28468761	195	204	expressed	T045	C0017262
28468761	208	219	neutrophils	T025	C0027950
28468761	237	248	upregulated	T044	C0041904
28468761	256	268	inflammation	T046	C0021368
28468761	291	299	CD177(+)	T028	C1824675
28468761	300	311	neutrophils	T025	C0027950
28468761	315	327	pathogenesis	T046	C0699748
28468761	331	334	IBD	T047	C0021390
28468761	352	362	Expression	T045	C0017262
28468761	366	371	CD177	T028	C1824675
28468761	388	404	peripheral blood	T031	C0229664
28468761	409	426	intestinal mucosa	T024	C0021839
28468761	432	440	patients	T101	C0030705
28468761	446	449	IBD	T047	C0021390
28468761	469	475	RT-PCR	T063	C0599161
28468761	477	491	flow cytometry	T059	C0016263
28468761	496	516	immunohistochemistry	T060	C0021044
28468761	518	526	CD177(+)	T028	C1824675
28468761	531	539	CD177(-)	T028	C1824675
28468761	540	551	neutrophils	T025	C0027950
28468761	579	583	gene	T028	C0017337
28468761	599	613	RNA sequencing	T059,T063	C0917793
28468761	615	622	Colitis	T047	C0009319
28468761	642	652	CD177(-/-)	T028	C1824675
28468761	657	671	wild-type mice	T015	C1520150
28468761	687	709	dextran sulfate sodium	T109,T121	C0079225
28468761	711	714	DSS	T109,T121	C0079225
28468761	749	757	CD177(+)	T028	C1824675
28468761	758	769	neutrophils	T025	C0027950
28468761	773	776	IBD	T047	C0021390
28468761	778	786	CD177(+)	T028	C1824675
28468761	787	798	neutrophils	T025	C0027950
28468761	826	842	peripheral blood	T031	C0229664
28468761	847	862	inflamed mucosa	T033	C3671082
28468761	868	876	patients	T101	C0030705
28468761	889	892	IBD	T047	C0021390
28468761	907	923	healthy controls	T080	C2986479
28468761	925	939	RNA sequencing	T059,T063	C0917793
28468761	967	982	gene expression	T045	C0017262
28468761	991	999	CD177(+)	T028	C1824675
28468761	1004	1012	CD177(-)	T028	C1824675
28468761	1013	1024	neutrophils	T025	C0027950
28468761	1030	1038	patients	T101	C0030705
28468761	1044	1047	IBD	T047	C0021390
28468761	1080	1097	bacterial defence	T040	C1327592
28468761	1099	1116	hydrogen peroxide	T121,T130,T197	C0020281
28468761	1121	1144	reactive oxygen species	T123,T196	C0162772
28468761	1146	1149	ROS	T123,T196	C0162772
28468761	1152	1160	CD177(+)	T028	C1824675
28468761	1161	1172	neutrophils	T025	C0027950
28468761	1198	1223	proinflammatory cytokines	T116,T129	C0079189
28468761	1229	1241	interferon-γ	T116,T121,T129	C0021745
28468761	1243	1261	interleukin (IL)-6	T116,T129	C0021760
28468761	1263	1269	IL-17A	T116,T192	C1705947
28468761	1293	1298	IL-22	T116,T129	C0961814
28468761	1303	1331	transforming growth factor-β	T116,T123	C0040690
28468761	1357	1380	bactericidal activities	T039	C0544570
28468761	1386	1389	ROS	T123,T196	C0162772
28468761	1391	1413	antimicrobial peptides	T116	C0030956
28468761	1415	1444	neutrophil extracellular trap	T026	C3850088
28468761	1460	1468	CD177(-)	T028	C1824675
28468761	1477	1487	CD177(-/-)	T028	C1824675
28468761	1488	1492	mice	T015	C0026809
28468761	1515	1522	colitis	T047	C0009319
28468761	1526	1529	DSS	T109,T121	C0079225
28468761	1552	1566	wild-type mice	T015	C1520150
28468761	1578	1583	CD177	T028	C1824675
28468761	1614	1632	intestinal barrier	T043	C3821032
28468761	1646	1668	antibacterial immunity	T039	C0020964
28468761	1701	1706	IL-22	T116,T129	C0961814
28468761	1710	1718	CD177(-)	T028	C1824675
28468761	1719	1730	neutrophils	T025	C0027950
28468761	1732	1740	CD177(+)	T028	C1824675
28468761	1741	1752	neutrophils	T025	C0027950
28468761	1827	1830	IBD	T047	C0021390
28468761	1849	1870	bactericidal activity	T039	C0544570
28468761	1875	1880	IL-22	T116,T129	C0961814
28468761	1903	1908	CD177	T028	C1824675
28468761	1913	1924	neutrophils	T025	C0027950
28468761	1947	1956	treatment	T061	C0087111
28468761	1960	1963	IBD	T047	C0021390